aTyr Pharma Inc (LIFE)
1.585
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
1.585
0.00 (0.00%)
After-Hours: 19:45
aTyr Pharma Cash from Operations (Quarterly): -11.06M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.06M |
| September 30, 2023 | -9.559M |
| June 30, 2023 | -12.01M |
| March 31, 2023 | -0.59M |
| December 31, 2022 | -10.37M |
| September 30, 2022 | -12.28M |
| June 30, 2022 | -9.117M |
| March 31, 2022 | -10.12M |
| December 31, 2021 | -8.086M |
| September 30, 2021 | -11.47M |
| June 30, 2021 | -7.692M |
| March 31, 2021 | -5.827M |
| December 31, 2020 | -5.401M |
| September 30, 2020 | -5.555M |
| June 30, 2020 | -6.403M |
| March 31, 2020 | 2.058M |
| December 31, 2019 | -4.916M |
| September 30, 2019 | -4.253M |
| June 30, 2019 | -4.821M |
| March 31, 2019 | -6.023M |
| Date | Value |
|---|---|
| December 31, 2018 | -4.839M |
| September 30, 2018 | -6.46M |
| June 30, 2018 | -9.187M |
| March 31, 2018 | -10.58M |
| December 31, 2017 | -10.31M |
| September 30, 2017 | -8.894M |
| June 30, 2017 | -9.276M |
| March 31, 2017 | -13.89M |
| December 31, 2016 | -11.70M |
| September 30, 2016 | -14.69M |
| June 30, 2016 | -13.99M |
| March 31, 2016 | -12.49M |
| December 31, 2015 | -9.835M |
| September 30, 2015 | -9.467M |
| June 30, 2015 | -11.21M |
| March 31, 2015 | -6.286M |
| December 31, 2014 | -5.801M |
| September 30, 2014 | -5.778M |
| June 30, 2014 | -4.90M |
| March 31, 2014 | -6.345M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-12.28M
Minimum
Sep 2022
2.058M
Maximum
Mar 2020
-7.235M
Average
-7.692M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Vaxart Inc | -13.52M |
| Allogene Therapeutics Inc | -53.71M |
| AIM ImmunoTech Inc | -9.758M |
| Protalix BioTherapeutics Inc | 3.595M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 17.82M |
| Cash from Financing (Quarterly) | 6.034M |
| Free Cash Flow | -37.44M |
| Free Cash Flow Per Share (Quarterly) | -0.1868 |
| Free Cash Flow Yield | -44.10% |